FasL expression in colorectal carcinoma and its significance in immune escape of cancer

Abstract

To study the significance of FasL expression in immune escape of colorectal carcinoma. FasL protein expression and the number of tumor infiltrating lymphocytes (TILs) in 80 specimens of colorectal carcinoma were detected by immunohistochemitry. The mRNA of FasL was measured byin situ hybridization in the consecutive tissue slices of 80 colorectal carcinomas respectively. Using terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL0, apoptotic cells were detected in 80 specimens of colorectal carcinoma. The expression of FasL was detected in all 80 specimens, but it was not even in the same or among different tissues. In the consecutive tissue slices, the location of expression of FasL protein corresponded with that of FasL mRNA. In those with FasL extensive expression, the number of TILs was less than that of FasL weak expression (P<0.05), and the apoptotic index (AI) of TILs was higher and that of tumor cells was lower than that of FasL with weak expression respectively (P<0.01). The AI of TILs was correlated with that of tumor cells (r=−0.631,P<0.01). It was suggested that colorectal carcinoma cells can induce the apoptosis of TILs through the expression of FasL, which can counterattack the immune system. This may be one of the mechanisms of immune evasion in colorectal carcinoma.

Keywords

colorectal carcinoma / Fas ligands / apoptosis / tumor-infiltrating lymphocytes / immune evasion

References

[1] NozoeT, YasudaM, HondaM, et al.. Fas ligand expression is correlated with metastasis in colorectal carcinoma. Oncology, 2003, 65(1): 83-88

[2] ShimoyamaM, KandaT, LiuL, et al.. Expression of Fas ligand is an early event in colorectal carcinogenesis. J Surg Oncol, 2001, 76(1): 63-68

[3] RopponenK M, EskelinenM J, LipponenP K, et al.. Prognostic value of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol, 1997, 182(3): 318-324

[4] OhtaT, ElnemrA, KitagawaH, et al.. Fas ligand expression in human pancreatic cancer. Oncol Rep, 2004, 12(4): 749-754

[5] LimS C. Fas-related apoptosis in gastric adenocarcinoma. Oncol Rep, 2003, 10(1): 57-63

[6] ShukuwaT, KatayamaI, KojiT. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas. Mod Pathol, 2002, 15(4): 387-396

[7] LeeT B, MinY D, LimS C, et al.. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells. J Gastroenterol Hepatol, 2002, 17(1): 32-38

[8] BennettM W, OconnellJ, OsullivanG C, et al.. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut, 1999, 44(2): 156-162

[9] OkadaK, KomutaK, HashimotoS, et al.. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis. Clin Cancer Res, 2000, 6(9): 3560-3564